Abbott Laboratories (NYSE:ABT) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Sell” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.
Abbott Laboratories (NYSE:ABT) lost -0.31 Percent and closed its previous trading session at $64.64. The stock traded with the average Volume of 5.07 Million at the end of last session.
Abbott Laboratories (NYSE:ABT) has the Market Capitalization of 112.54 Billion. The Stock has its 52-week High of $65.90 and 52-Week Low of $48.05 and it touched its 52-week high on 07/26/18 and 52-Week Low on 08/11/17
The company reported its last earnings Actual EPS of $0.73/share. While, the analyst predicted that the company could provide an EPS of $0.71/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.02/share which shows an Earnings Surprise of 2.8 Percent.
Sell side analysts plays vital role in buying and selling a stock where 7 analysts rated Abbott Laboratories (NYSE:ABT) as Buy, 0 analysts given Outperform signal, 0 reported Hold, and 1 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 0.52% where SMA50 and SMA200 are 2.57% and 8.25% respectively.
The company shows its Return on Assets (ROA) value of 1.3%. The Return on Equity (ROE) value stands at 3%. While it’s Return on Investment (ROI) value is 2.2%.
Abbott Laboratories (NYSE:ABT) currently has a Weekly Volatility of 0.98% percent while its Monthly Volatility is at 1.38% percent. While talking about Performance of the Stock, Abbott Laboratories currently has a Weekly performance of 0.09%, monthly performance percentage is 3.31 percent, Quarterly performance is 6.74 percent, 6 months performance shows a percent value of 14.87% and Yearly Performance is 32.54 percent.
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.